Recent Updates on the Guidelines to Clinical Trials through Innovations
The CDER Center for Clinical Trials Innovation (C3TI) was recently created by the FDA's Center for Drug Evaluation and Research (CDER) to facilitate and expand novel approaches to clinical trials intended to increase the effectiveness of drug development.
January 15, 2025
by Shruti Talashi
Emerging Therapies and Targets to Pain Management Market
Medication used to relieve pain is known as a pain management medication. They work well for mild to moderate discomfort, When used as prescribed, it's safe, but excessive dosages or liver disease might make it poisonous.
December 20, 2024
by Shruti Talashi
Globalization of drugs -A Double-Edged Sword with Room for Improvement
The pharmaceutical business has been experiencing globalization for a number of years due to factors such as the growing need for cutting-edge treatments in developing nations, the need for drug companies to cut costs, and the rising difficulties in recru
November 20, 2024
by Shruti Talashi
Global top 20 Best-Selling Race of Medicine by 2023
Top 20 medications by global sales list of 2023 was not without its surprises, given the year's significant patent expirations, the emergence of weight-loss medications, and other novel developments.
September 26, 2024
by Shruti Talashi
Trend in Enhancing Drug Development Efficiency
Pharmaceutical companies are exploring means to faster the steps in pharmaceutical development i.e. to go from the pre-clinical phase to clinical trials as efficiently as possible.
September 24, 2024
by Shruti Talashi